IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

Syncom Formulations

NSE:SYNCOMF · ISIN INE312C01025

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Syncom Formulations

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Trading Window - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing
Copy of Newspaper Publication - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Regulation 33(3)(D) Of SEBI (LODR) Regulations, 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report, Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March, 2026.BSE · financial results · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations, 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report, Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March, 2026.BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Syncom Formulations (India) LimitedNSE · financial results · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations, 2015 Regarding Intimation Of Holding Board Meeting For Consideration And Approval Of The Standalone And Consolidated Audited Financial Results, As On 31St March, 2026BSE · financial results · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated 30Th January, 2026.BSE · exchange filing · pdf
Source filing
Disclosure of material issue - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Forwarding Yearly Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011 By The Promoters Along With Their Person Acting In Concert('PAC') Of The Company For The Financial Year Ended On 31St March, 2026.BSE · shareholding · pdf
Source filing
General Updates - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Trading Window - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing
Copy of Newspaper Publication - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report, For The Quarter And Nine Months Ended On 31St December, 2025BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Syncom Formulations (India) LimitedNSE · financial results · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Intimation Of Holding 5/2025-26 Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results, For The Quarter Ended On 31St December, 2025.BSE · financial results · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Pursuant To Regulation 30 Read With Schedule III Part A Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing
General Updates - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Trading Window - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular SEBI/HO/CFD/Pod2/CIR/P/0155 Dated 11Th November, 2024. BSE · exchange filing · pdf
Source filing
General Updates - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing
Copy of Newspaper Publication - Syncom Formulations (India) LimitedNSE · exchange filing · pdf
Source filing